• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Illumina Inc.

Illumina launches state-of-the-art facility in Brazil

April 12, 2022 By Sean Whooley

Illumina (Nasdaq:ILMN) announced today that it launched a new state-of-the-art solution center in São Paulo, Brazil. San Diego-based Illumina selected Brazil as a location for the facility to reflect the increasing demand for and interest in clinical genomics as it seeks to expand access to such genomics in Latin America. According to a news release, Illumina’s […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics Tagged With: Illumina Inc.

Illumina launches new genomic profiling test for cancer in Europe

March 15, 2022 By Sean Whooley

Illumina (Nasdaq:ILMN) announced today that it launched its TruSight oncology test for assessing multiple tumor genes and biomarkers. San Diego-based Illumina’s CE-marked TruSight test, which will begin its global launch in Europe, assesses the tumor genes and biomarkers to reveal the specific molecular profile of a patient’s cancer, helping to inform precision medicine decisions. According […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, Oncology Tagged With: Illumina Inc.

Illumina appoints chief information officer

March 14, 2022 By Sean Whooley

Illumina (Nasdaq:ILMN) announced today that it appointed Carissa Rollins as its new chief information officer. A 30-year veteran of business technology transformation and digital and consumerization strategy, Rollins joins San Diego-based Illumina having most recently served as chief information officer (CIO) at UnitedHealthcare. Her appointment was made effective today. Rollins’ responsibilities at UnitedHealthcare included strategy […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, Oncology Tagged With: Illumina Inc., Personnel Moves

Baxter, 3M, Abbott near the top of Newsweek’s most responsible companies list

December 3, 2021 By Sean Whooley

Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek. The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of […]

Filed Under: Business/Financial News, Featured, News Well Tagged With: 3m, Abbott, Amerisource Bergen, Avanos Medical (formerly Halyard Health), Baxter, BD, Biogen, Boston Scientific, Cantel Medical Corp., Cardinal Health, Edwards Lifesciences, Gilead Sciences, Henry Schein, Hillrom, Hologic, Illumina Inc., Insulet, LabCorp, Merck, Pfizer, Quest Diagnostics Inc., ResMed, Thermo Fisher Scientific, Varex Imaging, Varian Medical Systems

Medtech M&A: The industry’s biggest mergers and acquisitions of 2021

November 5, 2021 By Sean Whooley

Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more. Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired. Here are the 10 biggest mergers and acquisitions in medtech in […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Baxter, Boston Scientific, GE Healthcare, Grail, Hillrom, Illumina Inc., Medtronic, PerkinElmer Inc., Philips, Roche, Sanofi, Siemens Healthineers, Thermo Fisher Scientific, Varian Medical Systems, Vectura

Illumina, Merck partner on diagnostics for identifying specific cancer mutations

September 7, 2021 By Sean Whooley

Illumina (NSDQ:ILMN) and Merck today announced a partnership to develop diagnostics for identifying certain genetic mutations. The partnership aims to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD), leveraging Illumina’s TruSight Oncology 500 (TSO 500) content, enabling what the companies tout as the most comprehensive genomic […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Oncology Tagged With: Illumina Inc., Merck

MedTech 100 roundup: Industry reaches another high point

August 30, 2021 By Sean Whooley

The medtech industry is continuing its massive 2021 boom, with the past week marking yet another record in the markets. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 27) at 121.05 points, representing a 1.2% rise from the 119.63-point mark set a week before. […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, Amazon, Boston Scientific, Encision Inc., Grail, Illumina Inc., iRhythm Technologies Inc., Johnson & Johnson, MedTech 100 Index, Medtronic, Philips

EU to investigate Illumina’s decision to close $8B Grail acquisition

August 23, 2021 By Sean Whooley

The European Commission announced that it opened an investigation to assess Illumina’s (NSDQ:ILMN) recently completed acquisition of Grail. Last week, Illumina completed its long-awaited, highly-scrutinized acquisition of the cancer detection company that spun out from Illumina nearly five years ago. The $8 billion acquisition was initially announced in September 2020. Within the announcement of the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Legal News, Mergers & Acquisitions, Oncology Tagged With: European Commission, Grail, Illumina Inc.

MedTech 100 roundup: On the rise again

August 23, 2021 By Sean Whooley

After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior. […]

Filed Under: Business/Financial News, Featured, Funding Roundup, MassDevice Earnings Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Alcon, Eli Lilly, Grail, Illumina Inc., Johnson & Johnson, MedTech 100 Index, Personnel Moves, Ra Medical, stevanato group, Strata Skin Sciences, Stryker, Ultrahuman

Illumina completes $8B Grail acquisition, companies remain separate amid European review

August 19, 2021 By Sean Whooley

Illumina (NSDQ:ILMN) announced that it completed its long-awaited and much-scrutinized acquisition of cancer detection company Grail. Illumina, however, also said in a news release that it will hold Grail as a separate company as the European Commission conducts an ongoing regulatory review. A decision from the EU regulators is projected after the deal expires, but […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Legal News, Mergers & Acquisitions, Oncology Tagged With: Grail, Illumina Inc.

MedTech 100 roundup: Rebound hits a snag

June 7, 2021 By Sean Whooley

Two weeks ago, medtech was on the rise following a rough stretch, but the past week brought the industry slightly back down to earth. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 4) at 106.96 points, producing a -1.4% dip from the 108.5-point mark […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, Abiomed, Grail, Illumina Inc., iRhythm Technologies Inc., LivaNova, MedTech 100 Index, Medtronic

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS